help button home button The Oncologist http://theoncologist.alphamedpress.org/subscriptions/etoc.dtl
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Anemia in Cancer: Some Pathophysiological Aspects
Right arrow eLetters: Submit a response to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dicato, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dicato, M.
The Oncologist, Vol. 8, Suppl 1, 19–21, February 2003
© 2003 AlphaMed Press

Anemia in Cancer: Some Pathophysiological Aspects

Mario Dicato

Haematology-Oncology, Luxembourg Medical Center, Luxembourg

Correspondence: Mario Dicato, M.D., Haematology-Oncology, Luxembourg Medical Center, L-1210 Luxembourg. Telephone: 352-4411-2084; Fax: 352-44-12-15; e-mail: dicato.mario{at}chl.lu

More than 30% of cancer patients experience anemia and its side effect, fatigue. Its causes can be numerous, but anemia is usually secondary to an imbalance of cytokines. Among these, tumor necrosis factor-alpha seems to be the major culprit, creating anemia by blunting the physiological effect of erythropoietin. Pharmacologically increasing the erythropoietin level corrects the anemia in about half the treated patients. Several studies have shown that quality of life is substantially improved through such therapy.

Key Words. Erythropoietin • TNF-alpha • Quality of life • Neoplasms




This article has been cited by other articles:


Home page
The OncologistHome page
J. L. Ryan, J. K. Carroll, E. P. Ryan, K. M. Mustian, K. Fiscella, and G. R. Morrow
Mechanisms of Cancer-Related Fatigue
Oncologist, May 1, 2007; 12(suppl_1): 22 - 34.
[Abstract] [Full Text] [PDF]


Home page
ptjournalHome page
T. Watson and V. Mock
Exercise as an Intervention for Cancer-Related Fatigue
Physical Therapy, August 1, 2004; 84(8): 736 - 743.
[Full Text] [PDF]


Home page
The OncologistHome page
P. A. Daly
Introduction: All Ireland Fatigue Coalition
Oncologist, February 1, 2003; 8(90001): 1 - 2.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS
http://theoncologist.alphamedpress.org/misc/eLetters.shtml

Copyright © 2003 by AlphaMed Press.